A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study
Sumeet K Reddy, Michael J Bailey, Richard W Beasley, Rinaldo Bellomo, Seton J Henderson, Diane M Mackle, Colin J McArthur, Jan E Mehrtens, John A Myburgh, Shay P McGuinness, Alex J Psirides, Paul J Young
Critical Care and Resuscitation | AUSTRALASIAN MED PUBL CO LTD | Published : 2014
Our study is an investigator-initiated study endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group and primarily funded by a research partnership grant from the Health Research Council of New Zealand. In addition, Baxter Healthcare is manufacturing and providing masked study fluid and a grant to support the study. Baxter Healthcare had no role in the development of the study protocol and all study analyses will be conducted independently of the funding organisations.